TLSA Tiziana Life Sciences Ltd

P/E --
Forward P/E --
Price/Sales --
Beta 0.44
Div Yield --
Market Cap --

Company Analysis

Latest News

🟢 Tiziana Life Sciences is trading 10% up in pre-market amid XBI's 2.61% pre-market gain

Tiziana Life Sciences is trading at $1.16, up 10.44%, with the move appearing mainly sector-driven. - No new company-specific announcement was reported on...

🟢 Tiziana Life Sciences is trading 10% up in after-hours trading amid broader biotech strength

Tiziana Life Sciences is trading at $1.16, up 10.48% after hours, with the move appearing mainly linked to broader biotech strength. - Shares gained 17.99%...

🟢 Tiziana Life Sciences is trading 7.62% up in after-hours trading amid biotech strength despite index declines

Tiziana Life Sciences is trading at $1.13, up 7.62% in after-hours trading, with the move appearing primarily linked to broader biotech strength despite...

🟢 Tiziana Life Sciences is trading 10.2% up today amid biotech outperformance as broader indices decline

Tiziana Life Sciences is trading 10.2% up at $0.98, with the move appearing driven mainly by biotech strength while broader indices decline. - No new...

🟢 Tiziana Life Sciences is trading 5.8% up today amid broader biotech strength

Tiziana Life Sciences is trading 5.8% up at $0.94, with broader biotech strength the clearest available explanation during September 23, 2026 trading. - No...

🟢 Tiziana Life Sciences is trading 5.6% up in pre-market alongside 2.61% biotech gains

Tiziana Life Sciences is trading 5.6% higher at $0.94, with broader biotech strength (up 2.61% pre-market) providing the clearest immediate explanation. -...

🔴 Tiziana Life Sciences is trading 5% down today

Tiziana Life Sciences is trading 5.15% down at $0.92, with no new negative company-specific announcement identified to explain the decline. - Shares rose...

🟢 Tiziana Life Sciences is trading 18.17% up today after non-binding MOU for MS trial

Tiziana Life Sciences is trading at $0.90 (+18.17%) after disclosing a non-binding MOU supporting a planned multiple-sclerosis trial. - The September 17, 2026...

Tiziana's Saudi Research Deal Lifts Shares 13% — But Can a Sub-Dollar Biotech With Months of Cash Turn an MOU Into Real Value?

Tiziana's Saudi Research Deal Lifts Shares 13% — But Can a Sub-Dollar Biotech With Months of Cash Turn an MOU Into Real Value?

Shares of Tiziana Life Sciences surged 12.8% to $0.87 after the company signed a memorandum of understanding — a non-binding statement of intent — with Saudi...

🟢 Tiziana Life Sciences is trading 12.83% up in pre-market after foralumab multiple sclerosis collaboration MOU

Tiziana Life Sciences is trading 12.83% up in pre-market at $0.87 after announcing a September 17, 2026 memorandum of understanding. - The MOU is with King...

🟢 Tiziana Life Sciences is trading 6% up in pre-market after a King Abdullah medical research MOU

Tiziana Life Sciences is trading 6.08% up at $0.82 after announcing a September 17, 2026 memorandum of understanding with King Abdullah International Medical...

🔴 Tiziana Life Sciences is trading 5.5% down today

Tiziana Life Sciences is trading 5.5% down at $0.84, with no clear company-specific announcement identified for September 15, 2026. - Shares closed at $0.89...

🟢 Tiziana Life Sciences is trading 5.9% up in after-hours trading

Tiziana Life Sciences is trading 5.9% up in after-hours trading at $0.94 after closing at $0.89 on September 14, 2026; no clear catalyst has been...

🔴 Tiziana Life Sciences is trading 5.2% down today amid broader risk-off sentiment

Tiziana Life Sciences is trading 5.2% down now at $0.91 amid broader risk-off sentiment. - The S&P 500 is down 0.57% and Nasdaq Composite down 0.61% on...

🔴 Tiziana Life Sciences is trading 5.6% down in pre-market with no clear company-specific catalyst identified

Tiziana Life Sciences is trading 5.6% down at $0.91 after falling from the September 10 close of $0.96, with no clear company-specific catalyst identified. -...

🟢 Tiziana Life Sciences is trading 5.8% up today after BTIG initiated coverage with a Buy rating

Tiziana Life Sciences is trading 5.8% up at $1.03 after BTIG initiated coverage with a Buy rating on September 3, 2026. - BTIG set a $7.00 price target,...

🟢 Tiziana Life Sciences is trading 5.7% up in after-hours trading after BTIG initiated coverage with a Buy rating

Tiziana Life Sciences is trading at $1.03 (+5.70%) in after-hours trading after BTIG initiated coverage with a Buy rating and a $7.00 price target. • Coverage...

🟢 Tiziana Life Sciences is trading 10% up today after BTIG initiated coverage with a Buy rating

Tiziana Life Sciences is trading at $1.02 (+10.04%) after BTIG initiated coverage with a Buy rating and $7.00 price target. - BTIG highlighted intranasal...

BTIG Slaps a $7 Target on a $1 Biotech Stock — Can Tiziana Life Sciences Actually Deliver 600% Upside?

BTIG Slaps a $7 Target on a $1 Biotech Stock — Can Tiziana Life Sciences Actually Deliver 600% Upside?

Shares of Tiziana Life Sciences jumped +7.4% to $1.00 after BTIG initiated coverage with a Buy rating and a $7.00 price target — implying roughly 650% upside...

🟢 Tiziana Life Sciences is trading 7.35% up today after BTIG initiated coverage with a Buy rating

Tiziana Life Sciences is trading at $1.00, up +7.35%, after BTIG initiated coverage on September 3, 2026, with a Buy rating and a $7.00 price target. • The...